Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 26 studies. P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age DAIDS Number 10655 Research Area Other Study Status Concluded P1071: CCR5 Vicriviroc (SCH-417690) DAIDS Number 10634 Research Area N/A Study Status Concluded P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded P1061s: Evaluation of Immunologic Mememory in HIV-Infected Children Treated with HAART. DAIDS Number 10132 Research Area Other Study Status Concluded P1059: Phase I Trial of Recombinant Vaccines in HIV+ Young Adults DAIDS Number 10051 Research Area Other Study Status Concluded P1051: Pharmacokinetic Study of Tipranavir with Ritonavir in HIV-infected Patients. DAIDS Number 10109 Research Area Other Study Status Concluded P1038: Safety of High Dose Lopinavir/Ritonavir with and without Saquinavir DAIDS Number 10045 Research Area Other Study Status Concluded P1024: Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine DAIDS Number 10269 Research Area Other Study Status Concluded P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded P1017: PEG-Intron in HIV+Children DAIDS Number 10317 Research Area Other Study Status Concluded Pagination Previous page Prev Page 1 Current page 2 Page 3 Next page Next
P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children <72 Months of Age DAIDS Number 10655 Research Area Other Study Status Concluded
P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded
P1061s: Evaluation of Immunologic Mememory in HIV-Infected Children Treated with HAART. DAIDS Number 10132 Research Area Other Study Status Concluded
P1059: Phase I Trial of Recombinant Vaccines in HIV+ Young Adults DAIDS Number 10051 Research Area Other Study Status Concluded
P1051: Pharmacokinetic Study of Tipranavir with Ritonavir in HIV-infected Patients. DAIDS Number 10109 Research Area Other Study Status Concluded
P1038: Safety of High Dose Lopinavir/Ritonavir with and without Saquinavir DAIDS Number 10045 Research Area Other Study Status Concluded
P1024: Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine DAIDS Number 10269 Research Area Other Study Status Concluded
P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded
